ROSUVASTATIN vs ROZANOLIXIZUMAB-NOLI: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ROSUVASTATIN vs ROZANOLIXIZUMAB-NOLI: Safety Overview
| Metric | ROSUVASTATIN | ROZANOLIXIZUMAB-NOLI |
|---|---|---|
| Total FAERS Reports | 36,332 | 349 |
| Deaths Reported | 1,536 | 4 |
| Death Rate | 4.2% | 1.1% |
| Hospitalizations | 11,195 | 84 |
| Average Patient Age | 66.1 yrs | 55.1 yrs |
| % Female Patients | 54.9% | 63.3% |
| FDA Approval Date | Apr 1, 2020 | N/A |
| Manufacturer | Umedica Laboratories USA Inc. | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | Prescription |